SARS-CoV-2 Omicron boosting induces de novo B cell response in humans

Wafaa B. Alsoussi(Washington University in St. Louis), Ali H. Ellebedy(Washington University in St. Louis), Spyros Chalkias(Moderna Therapeutics (United States)), Sharlene A. Teefey(Mallinckrodt (United States)), Jane A. O’Halloran(St. Vincent's University Hospital), Wooseob Kim(Korea University), Christopher W Farnsworth(Washington University in St. Louis), Birk Evavold(Washington University in St. Louis), Raffael Nachbagauer(Moderna Therapeutics (United States)), Fangjie Han(Guangzhou University), Katherine M. McIntire(Washington University in St. Louis), Tingting Lei(Washington University in St. Louis), Julian Q. Zhou(AbCellera (Canada)), Sameer Kumar Malladi(Washington University in St. Louis), Iskra Pusic(Washington University in St. Louis), Zhuoming Liu(Washington University in St. Louis), Rachel M. Presti(Johns Hopkins University), Stephen Horváth(Washington University in St. Louis), Aaron J. Schmitz(Washington University in St. Louis), Alexandria J. Sturtz(Washington University in St. Louis), William D. Middleton(Mallinckrodt (United States)), Jackson S. Turner(Washington University in St. Louis), Isabella F. Fox(Washington University in St. Louis), Biliana Nestorova(Moderna Therapeutics (United States)), Michael Diamond(Washington University in St. Louis), Robert Paris(GlaxoSmithKline (United States)), Sean P. J. Whelan(University of Pittsburgh Medical Center), Suzanne M. Scheaffer(Washington University in St. Louis), Michael K. Klebert(Washington University in St. Louis), Luis Parra-Rodriguez(Washington University in St. Louis), Baoling Ying(Washington University in St. Louis), Benjamin S. Strnad(Mallinckrodt (United States))
bioRxiv (Cold Spring Harbor Laboratory)
September 22, 2022
Cited by 40


Related Papers